Where does Aerovirus Technologies Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aerovirus Technologies Inc. ranks #44,484 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aerovirus Technologies Inc. hold?

Aerovirus Technologies Inc. holds 5 US utility patents granted between 2021 and 2023, spanning 9 technology areas.

What is Aerovirus Technologies Inc.'s Innovation Score?

Aerovirus Technologies Inc. has an Innovation Score of 43.2 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Aerovirus Technologies Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Aerovirus Technologies Inc..

What does claim depth mean for Aerovirus Technologies Inc.'s patents?

Aerovirus Technologies Inc.'s patents average 10.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aerovirus Technologies Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Aerovirus Technologies Inc.

Q: What technology areas does Aerovirus Technologies Inc. focus on?

Aerovirus Technologies Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 5 patents, ranking #840 of 2,502 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 9 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aerovirus ranks #44,484 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 9 technology areas.

#44,484
of 49,997 US assignees by volume: Top 29%
by Innovation Score (43.2/100): 10.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R44484 · Foreign Corporation #44,484 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
LOWER-Q #44,484/49,997
PHOTO-FINISH Aeovian Pharmaceutic…
CPC-NARROW C12Q · 9 areas
INNOV-PAR 43.2/100
CLAIMS-PAR 10.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Aeovian Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aerovirus’s 43.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (14%) Velocity 20.0 pts (46%) Breadth 10.6 pts (25%) Claim depth 6.4 pts (15%)

Qualcomm Incorporated · highest

85
Aerovirus · this assignee

43
3D Lighting… · lowest

7

What this shows Aerovirus's Innovation Score is 43.2/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aerovirus?

Each dot is one of Aerovirus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aerovirus’s own 10.6 claims/patent is at or below the 13.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aerovirus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aerovirus's grants concentrate

Aerovirus Technologies Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2021. By volume, Aerovirus sits between Aeovian Pharmaceuticals, Inc. and AFH Industries Inc..

Aerovirus's three-year grant acceleration

Aerovirus Technologies Inc. shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aeovian Pharmaceu…

5
Aequitas Innovati…

5
Aeroe Sports

5
Aerosens

5
Aerase

5
Aetc Sapphire

5
Affin AS

5
AFH Industries

5
Aerovirus ◀

5

What this shows Aerovirus holds 5 patents at rank #44,428, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aerovirus

By rank, the assignees closest to #44,428 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Aerovirus's primary technology class.

Aerovirus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Aerovirus Technologies Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	20.0%
2022	1	20.0%
2023	3	60.0%

Which technologies does Aerovirus Technologies Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C07K - Peptides 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

B01D - Separation 2

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aerovirus Technologies Inc.'s patent record in context - here's where to go next.

Aerovirus Technologies Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #44,484 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aerovirus Technologies Inc. against Aeovian Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.